Select the best EndPoints to reduce clinical trial delays and risks 

Clinical designer or director : make smarter decisions with our unique COA data & analytics

10 days

worth of publication screening saved by clinical team

45% more

unlocking massive datasets with cutting-edge AI technologies

100%

endpoints identified not registered in COA open databases

Image 1
PFE_BIG.D-8e6e4bdc (1)
output-onlinepngtools (1)
logo_white_sanofi (4) (1)
gsk-logo-white (1)
icm-logo-blanc-horiz (1)
InsermSeul_rvb_blanc_0 (1) (1)
output-onlinepngtools (6) (1)
output-onlinepngtools (4) (1)
CAP.PA_BIG.D-679c041e (1)
Image2

Struggling to find the right clinical Endpoint? Your Research is at Risk

Feeling overwhelmed by the "COA Maze"? Clinical endpoints or Clinical Outcome Assessments (COAs) are essential for your research, but choosing the wrong one can derail your entire project. Get answers to your questions : 

  • What type of PROMs to use in scientific studies: usage? scientific value? relevance of use?
  • How do we address patient advocacy groups?
  • What are the key environmental factors essential for breaking into the therapeutic sector?
  • Which inputs should be presented to scientific review boards?
  • What are the unmet needs of the target population?

Discover exclusive insights and accurate responses

Specific needs

Team mini

Your project is unique, share the details with us,

and we will build your dedicated team of experts :

  • Pharmacologists,
  • Biodata specialists,
  • AI experts,
  • Senior project managers
They will customize our standard solutions to meet your specific needs, delivering the perfect dataset in no time.

Testimonials

Riwan

Since using AS TrialDesigner, we can now provide our scientific committee with a systematic and comprehensive overview of current endpoint practices within our field. This has been invaluable in broadening their perspective and informing their decision-making process when it comes to selecting the most appropriate COAs for our clinical trials. The tool has saved us a significant amount of time and effort in research, allowing us to focus on the more strategic aspects of trial design.

Riwan E.

NIS Manager

Mirena

Before using AS TrialDesigner, we were flying blind when it came to competitor trials and their chosen endpoints. Now, with aTrialDesigner's comprehensive COA data and insights, we can see exactly what endpoints our competitors are focusing on. This has completely changed the way we design our own studies. We can now make more strategic decisions about which endpoints to include, giving us a significant edge in the race to regulatory approval.

Dr Marica A.

Clinical manager

Cinera

A.S. TrialDesigner was a game-changer for our research design process. We used to spend weeks manually sifting through literature to find relevant COAs. Now, with the tool's comprehensive data and insights, we can explore a wider range of options and make more informed decisions about the best PRO's for our specific needs. This has significantly improved the efficiency and effectiveness of our research.

Cirina M.

Project leader

Newsletter

Patients first in drug development with Artificial Intelligence